Last Updated: 18/06/2024
New aminobenzimidazole antimalarial agents with a novel mechanism of action
Objectives
This project seeks to identify the novel mechanism of action responsible for the activity of a new class of aminobenzimidazole antimalarials.
Principal Institution
Principal Investigators / Focal Persons
Rationale and Abstract
Malaria is a disease with a globally significant burden and distribution, including a presence in Australia’s northern neighbours East Timor, Indonesia and Papua New Guinea. Resistance to all major classes of antimalarial drugs has emerged in Asia in the last decade, meaning new antimalarials with unique mechanisms of action are urgently needed.
External reference
Date
Jan 2019 — Dec 2021
Total Project Funding
$533,507
Funding Details
National Health and Medical Research Council (NHMRC) Australia, Australia
Grant ID: 1163235
AUD 767,521
Project Site
Related Resources
